Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today ...
Roth MKM Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)
Roth MKM analyst Jason Wittes maintained a Buy rating on TriSalus Life Sciences (TLSI – Research Report) today and set a price target of ...
Spire Global’s Strategic Sale Enhances Financial Stability and Growth Prospects: Buy Rating Affirmed
Analyst Austin Moeller of Canaccord Genuity maintained a Buy rating on Spire Global (SPIR – Research Report), boosting the price target ...
Canaccord Genuity Group (TSE:CF) Price Target Raised to C$12.00
Canaccord Genuity Group (TSE:CF – Free Report) had its price target raised by TD Securities from C$10.00 to C$12.00 in a ...
Cormark Increases Canaccord Genuity Group (TSE:CF) Price Target to C$12.50
Canaccord Genuity Group (TSE:CF – Free Report) had its target price lifted by Cormark from C$11.50 to C$12.50 in a report issued on Tuesday,BayStreet.CA reports. Cormark also issued estimates for ...
The Mining Journal15h
Keep faith in gold: Canaccord
Despite gold's recent decline, major ASX resource sector fundraiser Canaccord Capital is still convinced the metal remains the commodity of choice going into ...